Moxetumomab pasudotox-tdfk Intravenous and Valganciclovir
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Valganciclovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: valganciclovir
Brand name: Valcyte
Synonyms: ValGANciclovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Valganciclovir Hydrochloride
- Moxetumomab pasudotox-tdfk Intravenous-Valganciclovir Oral Solution
- Moxetumomab pasudotox-tdfk Intravenous-Valganciclovir Solution
- Moxetumomab pasudotox-tdfk Intravenous-Valganciclovir Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Valisone
- Moxetumomab pasudotox-tdfk Intravenous-Valium
- Valganciclovir-Moxifloxacin
- Valganciclovir-Moxifloxacin (Systemic)
- Valganciclovir-Moxifloxacin Hydrochloride
- Valganciclovir-Moxifloxacin Injection
- Valganciclovir-Moxifloxacin Intravenous
- Valganciclovir-Moxifloxacin Tablets